417 related articles for article (PubMed ID: 17082594)
1. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
2. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
4. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
[TBL] [Abstract][Full Text] [Related]
5. Differential splicing of antigen-encoding RNA reduces endogenous epitope presentation that regulates the expansion and cytotoxicity of T cells.
Kienzle N; Buck M; Silins SL; Burrows SR; Moss DJ; Winterhalter A; Brooks A; Khanna R
J Immunol; 2000 Aug; 165(4):1840-6. PubMed ID: 10925262
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
7. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
9. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
[TBL] [Abstract][Full Text] [Related]
10. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
[TBL] [Abstract][Full Text] [Related]
12. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
[TBL] [Abstract][Full Text] [Related]
13. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.
Archbold JK; Macdonald WA; Gras S; Ely LK; Miles JJ; Bell MJ; Brennan RM; Beddoe T; Wilce MC; Clements CS; Purcell AW; McCluskey J; Burrows SR; Rossjohn J
J Exp Med; 2009 Jan; 206(1):209-19. PubMed ID: 19139173
[TBL] [Abstract][Full Text] [Related]
14. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
[TBL] [Abstract][Full Text] [Related]
15. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
Gagnon SJ; Wang Z; Turner R; Damirjian M; Biddison WE
J Immunol; 2003 Sep; 171(5):2233-41. PubMed ID: 12928367
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.
Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC
J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657
[TBL] [Abstract][Full Text] [Related]
17. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Dietrich PY; Le Gal FA; Dutoit V; Pittet MJ; Trautman L; Zippelius A; Cognet I; Widmer V; Walker PR; Michielin O; Guillaume P; Connerotte T; Jotereau F; Coulie PG; Romero P; Cerottini JC; Bonneville M; Valmori D
J Immunol; 2003 May; 170(10):5103-9. PubMed ID: 12734356
[TBL] [Abstract][Full Text] [Related]
18. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.
Kjer-Nielsen L; Clements CS; Brooks AG; Purcell AW; Fontes MR; McCluskey J; Rossjohn J
J Immunol; 2002 Nov; 169(9):5153-60. PubMed ID: 12391232
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
Yang X; Chen G; Weng NP; Mariuzza RA
J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
[TBL] [Abstract][Full Text] [Related]
20. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
